Asymmetrical Dimethylarginine: The Über Marker?

Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease

Schächinger, V., Britten, M. B., & Zeiher, A. M. (2000) · Circulation · doi:10.1161/01.cir.101.16.1899 · Cited by 2,589

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107

Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction

Suwaidi, J. M. S. A., Hamasaki, S., Higano, S. T., Nishimura, R. A., Holmes, D. R., & Lerman, A. (2000) · Circulation · doi:10.1161/01.cir.101.9.948 · Cited by 2,044

Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors

Vásquez-Vivar, J., Kalyanaraman, B., Martásek, P., Hogg, N., Masters, B. S. S., Karoui, H., Tordo, P., & Pritchard, K. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9220 · Cited by 1,484

Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction: Its Role in Hypercholesterolemia

Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study

Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087

Predictive value of noninvasivelydetermined endothelial dysfunction for long-term cardiovascular events inpatients with peripheral vascular disease

Gokce, N., Keaney, J. F., Hunter, L. M., Watkins, M. T., Nedeljkovic, Z. S., Menzoı́an, J. O., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00333-4 · Cited by 776

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

von der Leyen, H. E., Gibbons, G. H., Morishita, R., Lewis, N. P., Zhang, L., Nakajima, M., Kaneda, Y., Cooke, J. P., & Dzau, V. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1137 · Cited by 763

Endogenous Nitric Oxide Synthase Inhibitor

Miyazaki, H., Matsuoka, H., Cooke, J. P., Usui, M., Ueda, S., Okuda, S., & Imaizumi, T. (1999) · Circulation · doi:10.1161/01.cir.99.9.1141 · Cited by 756

NITRIC OXIDE SYNTHASE: Role in the Genesis of Vascular Disease

Cooke, J. P., & Dzau, V. J. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.489 · Cited by 706

Chronic Kidney Disease: Effects on the Cardiovascular System

Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448

Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?

Rehman, K., & Akash, M. S. H. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0303-y · Cited by 702

Pharmacokinetic and pharmacodynamic properties of oral L‐citrulline and L‐arginine: impact on nitric oxide metabolism

Schwedhelm, E., Maas, R., Freese, R., Jung, D., Lukacs, Z., Jambrecina, A., Spickler, W., Schulze, F., & Böger, R. H. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02990.x · Cited by 494

Nitric oxide and atherosclerosis: An update

Claudio Napoli, A., de Nigris, F., Williams‐Ignarro, S., Pignalosa, O., Sica, V., & Ignarro, L. J. (2006) · Nitric Oxide · doi:10.1016/j.niox.2006.03.011 · Cited by 471

Atherogenic Index of Plasma: Novel Predictive Biomarker for Cardiovascular Illnesses

Fernández-Macías, J. C., Ochoa-Martínez, A. C., Varela-Silva, J. A., & Pérez-Maldonado, I. N. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.08.009 · Cited by 458

Biomarkers in chronic kidney disease: a review

Fassett, R. G., Venuthurupalli, S. K., Gobe, G. C., Coombes, J. S., Cooper, M. A., & Hoy, W. E. (2011) · Kidney International · doi:10.1038/ki.2011.198 · Cited by 466

Disruption of methylarginine metabolism impairs vascular homeostasis

LEIPER, J. M., Nandi, M., Torondel, B., Murray‐Rust, J., Malaki, M., O'Hara, B. P., Rossiter, S., Anthony, S., Madhani, M., Selwood, D. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1543 · Cited by 408

Asymmetrical Dimethylarginine Predicts Progression to Dialysis and Death in Patients with Chronic Kidney Disease

Ravani, P., Tripepi, G. L., Malberti, F., Testa, S., Mallamaci, F., & Zoccali, C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010076 · Cited by 378

Symmetric dimethylarginine (SDMA) as endogenous marker of renal function–a meta-analysis

Kielstein, J. T., Salpeter, S. R., Bode-Boeger, S. M., Cooke, J. P., & Fliser, D. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl292 · Cited by 363

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population

Shah, N. H., LePendu, P., Bauer‐Mehren, A., Ghebremariam, Y. T., Iyer, S. V., Marcus, J. R., Nead, K. T., Cooke, J. P., & Leeper, N. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124653 · Cited by 332

Asymmetric Dimethylarginine and Progression of Chronic Kidney Disease

Fliser, D., Kronenberg, F., Kielstein, J. T., Morath, C. P., Bode‐Böger, S. M., Haller, H. G., & Ritz, E. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005020179 · Cited by 310

Symmetrical Dimethylarginine

Bode‐Böger, S. M., Scalera, F., Kielstein, J. T., Martens‐Lobenhoffer, J., Breithardt, G. D., Fobker, M., & Reinecke, H. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101119 · Cited by 300

Asymmetric Dimethylarginine, L-Arginine, and Endothelial Dysfunction in Essential Hypertension

Perticone, F., Sciacqua, A., Maio, R., Perticone, M., Maas, R., Böger, R. H., Tripepi, G., Sesti, G., & Zoccali, C. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.040 · Cited by 269

Unexpected Effect of Proton Pump Inhibitors

Ghebremariam, Y. T., LePendu, P., Lee, J. C., Erlanson, D. A., Slaviero, A., Shah, N. H., LEIPER, J. M., & Cooke, J. P. (2013) · Circulation · doi:10.1161/circulationaha.113.003602 · Cited by 258

Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay

Schulze, F., Wesemann, R., Schwedhelm, E., Sydow, K., Albsmeier, J., Cooke, J. P., & Böger, R. H. (2004) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2004.257 · Cited by 252

Olive Oil Polyphenols Decrease Blood Pressure and Improve Endothelial Function in Young Women with Mild Hypertension

Moreno‐Luna, R., Múñoz‐Hernández, R., Miranda, M. L., Costa, A. F., Jiménez-Jiménez, L., Vallejo‐Vaz, A. J., Muriana, F. J. G., Villar, J. R., & Stiefel, P. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.128 · Cited by 243

l -Arginine Supplementation in Peripheral Arterial Disease: No Benefit and Possible Harm

Wilson, A. M., Harada, R., Nair, N., Balasubramanian, N., & Cooke, J. P. (2007) · Circulation · doi:10.1161/circulationaha.106.683656 · Cited by 241

Acute Effects of High-Fat Meals Enriched With Walnuts or Olive Oil on Postprandial Endothelial Function

Cortés, B., Núñez, I., Cofán, M., Gilabert, R., Pérez-Heras, A., Casals, E., Deulofeu, R., & Ros, E. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.057 · Cited by 239

Asymmetric dimethylarginine (ADMA): A novel risk marker in cardiovascular medicine and beyond

Böger, R. H. (2006) · Annals of Medicine · doi:10.1080/07853890500472151 · Cited by 238

Asymmetrical Dimethylarginine Independently Predicts Total and Cardiovascular Mortality in Individuals with Angiographic Coronary Artery Disease (The Ludwigshafen Risk and Cardiovascular Health Study)

Meinitzer, A., Seelhorst, U., Wellnitz, B., Halwachs‐Baumann, G., Boehm, B. O., Winkelmann, B. R., & März, W. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.076711 · Cited by 227

Association of Oxidative Stress, Insulin Resistance, and Diabetes Risk Phenotypes

Meigs, J. B., Larson, M. G., Fox, C. S., Keaney, J. F., Vasan, R. S., & Benjamin, E. J. (2007) · Diabetes Care · doi:10.2337/dc07-0817 · Cited by 220

The role of obesity in preeclampsia

Roberts, J. M., Bodnar, L. M., Patrick, T. E., & Powers, R. W. (2010) · Pregnancy Hypertension · doi:10.1016/j.preghy.2010.10.013 · Cited by 214

The Deleterious Effects of Hyperglycemia on Platelet Function in Diabetic Patients With Acute Coronary Syndromes

Worthley, M. I., Holmes, A. S., Willoughby, S. R., Kucia, A. M., Heresztyn, T., Stewart, S., Chirkov, Y. Y., Zeitz, C. J., & Horowitz, J. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.053 · Cited by 188

Vascular Incompetence in Dialysis Patients—Protein‐Bound Uremic Toxins and Endothelial Dysfunction

Jourde‐Chiche, N., Dou, L., Cérini, C., Dignat‐George, F., & Brunet, P. (2011) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2011.00925.x · Cited by 193

Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study

Schulze, F., Lenzen, H., Hanefeld, C., Bartling, A., Osterziel, K. J., Goudeva, L., Schmidt‐Lucke, C., Kusus, M., Maas, R., Schwedhelm, E., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.06.005 · Cited by 185

ADMA metabolism and clearance

Teerlink, T. (2005) · Vascular Medicine · doi:10.1191/1358863x05vm597oa · Cited by 185

Resveratrol Reverses Endothelial Nitric-Oxide Synthase Uncoupling in Apolipoprotein E Knockout Mice

Xia, N., Daiber, A., Habermeier, A., Closs, E. I., Thum, T., Spanier, G., Lü, Q., Oelze, M. W., Torzewski, M., Lackner, K. J., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168724 · Cited by 186

Adverse Effects of Cigarette Smoke on NO Bioavailability

Zhang, W., Venardos, K. M., Chin-Dusting, J. P. F., & Kaye, D. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000231509.27406.42 · Cited by 180

Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension

Pullamsetti, S. S., Kiss, L., Ghofrani, H. A., Voswinckel, R., Haredza, P., Klepetko, W., Aigner, C., Fink, L., Muyal, J. P., Weißmann, N., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3223fje · Cited by 177

Asymmetric Dimethylarginine: A Cardiovascular Risk Factor and a Uremic Toxin Coming of Age?

Kielstein, J. T., & Zoccali, C. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.05.009 · Cited by 171

Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis

Gritters, M., Grooteman, M. P. C., Schoorl, M. G., Schoorl, M., Bartels, P. C. M., Scheffer, P. G., Teerlink, T., Schalkwijk, C. G., Spreeuwenberg, M. D., & Nubé, M. J. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi069 · Cited by 163

HPLC analysis of ADMA and other methylated l-arginine analogs in biological fluids

Teerlink, T. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.07.024 · Cited by 155

Prevention of Atherosclerosis by Interference with the Vascular Nitric Oxide System

Li, H., & Förstermann, U. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789058002 · Cited by 154

Upregulation of Endothelial and Inducible Nitric Oxide Synthase Expression by Reactive Oxygen Species

Zhen, J., Lu, H., Wang, X. Q., Vaziri, N. D., & Zhou, X. J. (2007) · American Journal of Hypertension · doi:10.1038/ajh.2007.14 · Cited by 147

Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis

Schulz, R., Rassaf, T., Massion, P. B., Kelm, M., & Balligand, J. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.005 · Cited by 149

Soluble RAGE in type 2 diabetes: Association with oxidative stress

Devangelio, E., Santilli, F., Formoso, G., Ferroni, P., Bucciarelli, L. G., Michetti, N., Clissa, C., Ciabattoni, G., Consoli, A., & Davı̀, G. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.015 · Cited by 147

Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes

Schepers, E., Glorieux, G., Dhondt, A., Leybaert, L., & Vanholder, R. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn670 · Cited by 145

Decreased Exhaled Nitric Oxide in Pulmonary Arterial Hypertension

Girgis, R. E., Champion, H. C., Diette, G. B., Johns, R. A., Permutt, S., & SYLVESTER, J. T. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200412-1684oc · Cited by 144

Depression, heart rate related variables and cardiovascular disease

Taylor, C. B. (2010) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2010.04.006 · Cited by 147

Symmetric Dimethylarginine as a Proinflammatory Agent in Chronic Kidney Disease

Schepers, E., Barreto, D. V., Liabeuf, S., Glorieux, G., Eloot, S., Barreto, F. C., Massy, Z. A., & Vanholder, R. C. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01720211 · Cited by 144

Overexpression of Dimethylarginine Dimethylaminohydrolase Reduces Tissue Asymmetric Dimethylarginine Levels and Enhances Angiogenesis

Jacobi, J., Sydow, K., von Degenfeld, G., Zhang, Y., Dayoub, H., Wang, B., Patterson, A. J., Kimoto, M., Blau, H. M., & Cooke, J. P. (2005) · Circulation · doi:10.1161/01.cir.0000158487.80483.09 · Cited by 143

Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction

Fujii, H., Goto, S., & Fukagawa, M. (2018) · Toxins · doi:10.3390/toxins10050202 · Cited by 142

Asymmetric Dimethylarginine Independently Predicts Fatal and Nonfatal Myocardial Infarction and Stroke in Women

Leong, T., Zylberstein, D. E., Graham, I. M., Lissner, L., Ward, D., Fogarty, J., Bengtsson, C., Björkelund, C., & Thelle, D. S. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.156596 · Cited by 141

High-throughput, low-volume, multianalyte quantification of plasma metabolites related to one-carbon metabolism using HPLC-MS/MS

Midttun, Ø., Kvalheim, G., & Ueland, P. M. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6602-6 · Cited by 137

Brachial Artery Flow-Mediated Dilation and Asymmetrical Dimethylarginine in the Cardiovascular Risk in Young Finns Study

Juonala, M., Viikari, J. S. A., Alfthan, G., Marniemi, J., Kähönen, M. A. P., Taittonen, L. M., Laitinen, T. T., & Raitakari, O. T. (2007) · Circulation · doi:10.1161/circulationaha.107.690016 · Cited by 133

Oleuropein: A natural antioxidant molecule in the treatment of metabolic syndrome

Ahamad, J., Toufeeq, I., Khan, M. A., Ameen, M. S. M., Anwer, E. T., Uthirapathy, S., Mir, S. R., & Ahmad, J. (2019) · Phytotherapy Research · doi:10.1002/ptr.6511 · Cited by 140

Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD

Mallamaci, F., Tripepi, G. L., Cutrupi, S., Malatino, L., & Zoccali, C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00338.x · Cited by 132

Update on the Pharmacokinetics and Redox Properties of Protein-Bound Uremic Toxins

Watanabe, H., Miyamoto, Y., Otagiri, M., & Maruyama, T. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22592 · Cited by 131

Microcirculation and oxidative stress

Crimi, E., Ignarro, L. J., & Claudio Napoli, A. (2007) · Free Radical Research · doi:10.1080/10715760701732830 · Cited by 123

Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials

Böger, R. H. (2005) · Vascular Medicine · doi:10.1177/1358836x0501000104 · Cited by 120

Anti‐Atherosclerotic Effects of Vitamins D and E in Suppression of Atherogenesis

Rashidi, B., Hoseini, Z. S., Sahebkar, A., & Mirzaei, H. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25738 · Cited by 118

Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium

Ding, H., & Triggle, C. R. (2005) · Vascular Health and Risk Management · doi:10.2147/vhrm.1.1.55.58939 · Cited by 118

The Clinical Significance of Asymmetric Dimethylarginine

Siroen, M. P. C., Teerlink, T., Nijveldt, R. J., Prins, H. A., Richir, M. C., & van Leeuwen, P. A. M. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111320 · Cited by 116

Fast and Efficient Determination of Arginine, Symmetric Dimethylarginine, and Asymmetric Dimethylarginine in Biological Fluids by Hydrophilic-Interaction Liquid Chromatography–Electrospray Tandem Mass Spectrometry

Martens‐Lobenhoffer, J., & Bode‐Böger, S. M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.060152 · Cited by 113

L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.

Böger, R. H., & Ron, E. S. (2005) · PubMed · Cited by 112

Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA)

Maas, R. (2005) · Vascular Medicine · doi:10.1191/1358863x05vm605oa · Cited by 113

Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA

Sydow, K., Mondon, C. E., & Cooke, J. P. (2005) · Vascular Medicine · doi:10.1177/1358836x0501000106 · Cited by 114

Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor

Cooke, J. P. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.01.061 · Cited by 113

Endometriosis: Perspective, lights, and shadows of etiology

Asghari, S., Valizadeh, A., Maleki, L. A., Nouri, M., & Yousefi, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.109 · Cited by 110

Aspirin reduces endothelial cell senescence

Bode‐Böger, S. M., Martens‐Lobenhoffer, J., Täger, M., Schröder, H., & Scalera, F. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.014 · Cited by 111

Symmetrical and Asymmetrical Dimethylarginine as Predictors for Mortality in Patients Referred for Coronary Angiography: The Ludwigshafen Risk and Cardiovascular Health Study

Meinitzer, A., Kielstein, J. T., Pilz, S., Drechsler, C., Ritz, E., Boehm, B. O., Winkelmann, B. R., & März, W. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.150854 · Cited by 104

Dimethylarginine Dimethylaminohydrolase Overexpression Suppresses Graft Coronary Artery Disease

Tanaka, M., Sydow, K., Gunawan, F., Jacobi, J., Tsao, P. S., Robbins, R. C., & Cooke, J. P. (2005) · Circulation · doi:10.1161/circulationaha.105.537670 · Cited by 103

Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis

Elesber, A. A., Solomon, H., Lennon, R. J., Mathew, V., Prasad, A., Pumper, G. M., Nelson, R. E., McConnell, J. P., Lerman, L. O., & Lerman, A. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi749 · Cited by 103

Dimethylarginine Dimethylaminohydrolase Overexpression Enhances Insulin Sensitivity

Sydow, K., Mondon, C. E., Schrader, J., Konishi, H., & Cooke, J. P. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.162073 · Cited by 102

Short-term physical inactivity impairs vascular function

Nosova, E. V., Yen, P. K., Chong, K. C., Alley, H. F., Stock, E. O., Quinn, A., Hellmann, J. L., Conte, M. S., Owens, C. D., Spite, M. R., et al. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.02.001 · Cited by 102

Erythropoietin Increases Asymmetric Dimethylarginine in Endothelial Cells

Scalera, F., Kielstein, J. T., Martens‐Lobenhoffer, J., Postel, S. C., Diaeresis]ger, M. T., & Bode‐Böger, S. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090735 · Cited by 97

Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events

Krempl, T., Maas, R., Sydow, K., Meinertz, T., Böger, R. H., & Kahler, J. P. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi287 · Cited by 94

Predictors of Cardiovascular Death in ESRD

Zoccali, C., Tripepi, G. L., & Mallamaci, F. (2005) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2005.05.002 · Cited by 92

Psychophysiological and Cortisol Responses to Psychological Stress in Depressed and Nondepressed Older Men and Women With Elevated Cardiovascular Disease Risk

Taylor, C. B., Conrad, A., Wilhelm, F. H., Neri, E., DeLorenzo, A., Kramer, M. A., Giese‐Davis, J., Roth, W. T., Oka, R. K., Cooke, J. P., et al. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000222372.16274.92 · Cited by 93

Role of the eNOS Uncoupling and the Nitric Oxide Metabolic Pathway in the Pathogenesis of Autoimmune Rheumatic Diseases

Łuczak, A., Madej, M., Kasprzyk, A., & Doroszko, A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1417981 · Cited by 95

Atherosclerosis and Oxidant Stress: The End of the Road for Antioxidant Vitamin Treatment?

Thomson, M. J. C. B., Püntmann, V. O., & Kaski, J. C. (2007) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-007-6027-1 · Cited by 91

Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants

Speer, P. D., Powers, R. W., Frank, M. P., Harger, G. F., Marković, N., & Roberts, J. M. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.05.052 · Cited by 88

Long‐term use of proton pump inhibitors, dose–response relationship and associated risk of ischemic stroke and myocardial infarction

Sehested, T. S. G., Gerds, T. A., Fosbøl, E. L., Hansen, P. W., Charlot, M. G., Carlson, N., Hlatky, M. A., Torp-Pedersen, C. T., & Gislason, G. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12698 · Cited by 84

Overexpression of Dimethylarginine Dimethylaminohydrolase Inhibits Asymmetric Dimethylarginine–Induced Endothelial Dysfunction in the Cerebral Circulation

Dayoub, H., Rodionov, R. N., Lynch, C. M., Cooke, J. P., Arning, E., Bottiglieri, T., Lentz, S. R., & Faraci, F. M. (2007) · Stroke · doi:10.1161/strokeaha.107.490631 · Cited by 83

Asymmetric Dimethylarginine Determines the Improvement of Endothelium-Dependent Vasodilation by Simvastatin

Böger, G. I., Rudolph, T. K., Maas, R., Schwedhelm, E., Dumbadze, E., Bierend, A., Benndorf, R. A., & Böger, R. H. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.051 · Cited by 80

AGXT2: a promiscuous aminotransferase

Rodionov, R. N., Jarzebska, N., Weiss, N., & Lentz, S. R. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.09.005 · Cited by 79

Cross-sectional associations between physical activity and selected coronary heart disease risk factors in young adults. The Cardiovascular Risk in Young Finns Study

Mansikkaniemi, K., Juonala, M., TAIMELA, S. P., Hirvensalo, M. H., Telama, R., Huupponen, R., Saarikoski, L. A., Hurme, M., Mallat, Z., Bénessiano, J., et al. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.590146 · Cited by 82

Kidney dysfunction in patients with pulmonary arterial hypertension

Nickel, N. P., O’Leary, J. M., Brittain, E. L., Fessel, J. P., Zamanian, R. T., West, J. D., & Austin, E. D. (2016) · Pulmonary Circulation · doi:10.1086/690018 · Cited by 79

Chromatographic-mass spectrometric methods for the quantification of l-arginine and its methylated metabolites in biological fluids

Martens‐Lobenhoffer, J., & Bode‐Böger, S. M. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.07.038 · Cited by 75

Effect of Telmisartan on Nitric Oxide–Asymmetrical Dimethylarginine System

Scalera, F., Martens‐Lobenhoffer, J., Bukowska, A., Lendeckel, U., Täger, M., & Bode‐Böger, S. M. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.104570 · Cited by 73

Diabetes, obesity, and erectile dysfunction

Tamler, R. (2009) · Gender Medicine · doi:10.1016/j.genm.2008.12.003 · Cited by 73

Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance

Teerlink, T. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.197 · Cited by 72

Asymmetric Dimethylarginine and Reduced Nitric Oxide Bioavailability in Young Black African Men

Melikian, N., Wheatcroft, S. B., Ogah, O. S., Murphy, C., Chowienczyk, P., Wierzbicki, A. S., Sanders, T. A. B., Jiang, B., Duncan, E. R., Shah, A. M., et al. (2007) · Hypertension · doi:10.1161/01.hyp.0000258405.25330.80 · Cited by 70

Endurance training reduces circulating asymmetric dimethylarginine and myeloperoxidase levels in persons at risk of coronary events

Penka, M., Rajković, M. G., Steiner, S., Strasser, B., Ziegler, S., Zorn, G., Maurer, G., Simeon-Rudolf, V., Wojta, J., Huber, K., et al. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-03-0158 · Cited by 71

Asymmetric dimethylarginine (ADMA): the silent transition from an ‘uraemic toxin’ to a global cardiovascular risk molecule

Fliser, D. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01457.x · Cited by 71

Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease

Wilson, A., Shin, D. S., Weatherby, C., Harada, R. K., Ng, M. K., Nair, N., Kielstein, J. T., & Cooke, J. P. (2010) · Vascular Medicine · doi:10.1177/1358863x10364552 · Cited by 67

Structure of the Mammalian NOS Regulator Dimethylarginine Dimethylaminohydrolase: A Basis for the Design of Specific Inhibitors

Frey, D., Braun, O., Briand, C., Vašák, M., & Grütter, M. G. (2006) · Structure · doi:10.1016/j.str.2006.03.006 · Cited by 67

Pathogenic Cycle Between the Endogenous Nitric Oxide Synthase Inhibitor Asymmetrical Dimethylarginine and the Leukocyte-Derived Hemoprotein Myeloperoxidase

von Leitner, E.-C., Klinke, A., Atzler, D., Slocum, J. L., Lund, N., Kielstein, J. T., Maas, R., Schmidt-Haupt, R., Pekarová, M., Hellwinkel, O., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.060541 · Cited by 66

Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move

Zoccali, C. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000217839.26971.8d · Cited by 66

Effects of ADMA upon Gene Expression: An Insight into the Pathophysiological Significance of Raised Plasma ADMA

Smith, C. L., Anthony, S., Hubank, M. J. F., LEIPER, J. M., & Vallance, P. J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020264 · Cited by 66

Simultaneous quantitative determination of NG,NG-dimethyl-l-arginine or asymmetric dimethylarginine and related pathway's metabolites in biological fluids by ultrahigh-performance liquid chromatography/electrospray ionization-tandem mass spectrometry

Gangi, I. M. D., Chiandetti, L., Gucciardi, A., Moret, V., Naturale, M., & Giordano, G. (2010) · Analytica Chimica Acta · doi:10.1016/j.aca.2010.08.011 · Cited by 66

Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality

Böger, R. H., Maas, R., Schulze, F., & Schwedhelm, E. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.196 · Cited by 65

Dimethylarginine Dimethylaminohydrolase Overexpression Ameliorates Atherosclerosis in Apolipoprotein E-Deficient Mice by Lowering Asymmetric Dimethylarginine

Jacobi, J., Maas, R., Cardounel, A. J., Arend, M., Pope, A. J., Cordasic, N., Heusinger‐Ribeiro, J., Atzler, D., Strobel, J., Schwedhelm, E., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090614 · Cited by 65

Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease

Kielstein, J. T., & Zoccali, C. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328314b6ca · Cited by 62

Aerobic Exercise Training Decreases Plasma Asymmetric Dimethylarginine Concentrations With Increase in Arterial Compliance in Postmenopausal Women

Tanahashi, K., Akazawa, N., Miyaki, A., Choi, Y., Ra, S., Matsubara, T., Kumagai, H., Oikawa, S., & Maeda, S. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt217 · Cited by 61

Androgen Deficiency and Endothelial Dysfunction in Men with End-Stage Kidney Disease Receiving Maintenance Hemodialysis

Karakitsos, D., Patrianakos, A. P., de Groot, E., Boletis, J., Karabinis, A., Kyriazis, J., Samonis, G., Parthenakis, F. I., Vardas, P. E., & Daphnis, E. K. (2006) · American Journal of Nephrology · doi:10.1159/000097816 · Cited by 61

Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in vitro Evaluation

Schepers, E., Glorieux, G., Dou, L., Cérini, C., Gayrard, N., Louvet, L., Maugard, C., Preus, P., Rodríguez-Ortiz, M. E., Argilés, À., et al. (2010) · Blood Purification · doi:10.1159/000320765 · Cited by 60

Quantification of l-arginine, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma: A step improvement in precision by stable isotope dilution mass spectrometry

Martens‐Lobenhoffer, J., & Bode‐Böger, S. M. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2012.07.021 · Cited by 60

Nitric oxide and reactive oxygen species in limb vascular function: what is the effect of physical activity?

Gliemann, L., Nyberg, M., & Hellsten, Y. (2013) · Free Radical Research · doi:10.3109/10715762.2013.835045 · Cited by 60

ADMA, C-Reactive Protein, and Albuminuria in Untreated Essential Hypertension: A Cross-sectional Study

Tsioufis, C. P., Dimitriadis, K. S., Andrikou, E., Thomopoulos, C., Tsiachris, D., Stefanadi, E., Mihas, C. C., Miliou, A., Papademetriou, V., & Stefanadis, C. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.11.024 · Cited by 58

Asymmetric Dimethylarginine and Atherosclerosis

Qin, J. (2003) · Advances in Cardiovascular Diseases

Asymmetric Dimethylarginine and Cerebrovascular Disorders in Humans

Tsuda, K. (2006) · Stroke · doi:10.1161/01.str.0000248209.76578.3a

Original Article Handling of asymmetrical dimethylarginine and symmetrical

Nijveldt, R. J., Teerlink, T., Guldener, C. V., Prins, H. A., van Lambalgen, A. A., Stehouwer, C. D. A., Rauwerda, J. A., & van Leeuwen, P. A. M. (2015)

Do Homoarginine and Asymmetric Dimethylarginine Act Antagonistically in the Cardiovascular System?

Tsikas, D., & Kayacelebi, A. A. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0484 · Cited by 35

Abstract 4054: Determinants of Circulating Asymmetric Dimethylarginine, Monomethylarginine and L-Arginine: A Population-Based Study

Chirinos, J. A., Lezama, J. M., David, R., Bralley, J. A., Vargas, O. L. M., Zea-Díaz, H., Bolaños, J., Valdivia-Ascuña, Z., Diaz, S. P., Medina, F. F. C., et al. (2006) · Circulation